id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-4299-0006,FDA,FDA-2023-D-4299,Request for Extension from Biotechnology Innovation Organization (BIO),Other,Request for Extension,2024-03-13T04:00:00Z,2024,3,2024-03-13T04:00:00Z,,2024-03-13T21:21:08Z,,0,0,0900006486478ce8
FDA-2023-D-4299-0002,FDA,FDA-2023-D-4299,Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry,Other,Guidance,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-03-28T03:59:59Z,2024-11-12T06:25:10Z,,1,0,0900006486364261
FDA-2023-D-4299-0001,FDA,FDA-2023-D-4299,Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T16:34:21Z,2023-28596,0,0,090000648636182c